Skip to content

Study on the effect of Qishe Pill on functional recovery of patients after Cervical surgery and its Mechanism of delaying Intervertebral Disc degeneration

Study on the effect of Qishe Pill on functional recovery of patients after Cervical surgery and its Mechanism of delaying Intervertebral Disc degeneration

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004580
Enrollment
Unknown
Registered
2021-03-14
Start date
2021-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

Sponsors

Dongzhimen Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40 to 70 years old; 2. Preoperative compliance with the diagnostic criteria and surgical indications of cervical spondylosis; 3. Surgical treatment of cervical vertebrae (anterior approach) for the first time; 4. In line with the diagnostic criteria of TCM syndromes and the syndrome differentiation of qi deficiency and blood stasis; 5. The patients voluntarily joined the trial and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who meet the above diagnostic criteria, but whose vital signs are not stable after operation; 2. Patients with severe primary diseases such as liver, kidney, hematopoietic system and endocrine system; 3. A woman who is breastfeeding or preparing for pregnancy; 4. Suspected or diagnosed with myelopathy and / or central nervous system diseases with changes in muscle tone (e.g. stroke, stroke sequelae, syringomyelia, muscular dystrophy, etc.); 5. Have received other relevant treatment, which may affect the observer of the effect index in this study; 6. Those who cannot tolerate or are allergic to treatment; 7. There are mental disorders that can't cooperate with researchers; 8. Other researchers believe that it is not appropriate for patients to participate in this study.

Design outcomes

Primary

MeasureTime frame
JOA;

Secondary

MeasureTime frame
SF-36;VAS;NDI;

Countries

China

Contacts

Public ContactJiang Chen

Dongzhimen Hospital

42691631@qq.com+86 13810599089

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026